Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity

References

• Lanzavecchia A, Sallustoa AF. Regulation of T cell immunity by dendritic cells. Cell 2001; 106:263-6; PMID:11509174; http://dx.doi.org/10.1016/S0092-8674(01)00455-X
   PubMed Web of Science ®Google Scholar
• Mellman I, Steiman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106:255-8; PMID:11509172; http://dx.doi.org/10.1016/S0092-8674(01)00449-4
   PubMed Web of Science ®Google Scholar
• Takei M, Umeyama A, Shoji N, Hashimoto T. Polyacetylenediols regulate the function of human monocyte-derived dendritic cells. Int Immunopharmacol 2010; 10: 913-21; PMID:20493278; http://dx.doi.org/10.1016/j.intimp.2010.05.002
   PubMed Web of Science ®Google Scholar
• Heiser A, Coleman D, Dannull J, Yancey D, Maurice MA, Lallas CD,. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest 2002; 109: 409-17; PMID:11828001; http://dx.doi.org/10.1172/JCI0214364
   PubMed Web of Science ®Google Scholar
• O'Rourke MG, Johnson M, Lanagan C, See J, Yang J, Bell JR,. Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine. Cancer Immunol Immunother 2003; 52: 387-95; PMID:12682787
   PubMed Web of Science ®Google Scholar
• Trepiakas R, Pedersen AE, Met O, Svane IM. Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function. Vaccine 2009; 27:2213-9; PMID:19428835; http://dx.doi.org/10.1016/j.vaccine.2009.02.015
   PubMed Web of Science ®Google Scholar
• Ribas A, Butterfield LH, Glaspy JA, Economou JS. Current developments in cancer vaccines and cellular immunotherapy. J Clin Oncol 2003; 21:2415-32; PMID:12805342; http://dx.doi.org/10.1200/JCO.2003.06.041
   PubMed Web of Science ®Google Scholar
• Joo HJ, Kim HS, Choi YS, Kim H, Kim SJ, Moon WK. Detection of prostaglandin E2-induced dendritic cell migration into the lymph nodes of mice using a 1.5 T clinical MR scanner. NMR Biomed 2012; 25:570-9; PMID:22009917; http://dx.doi.org/10.1002/nbm.1774
   PubMed Web of Science ®Google Scholar
• Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med 2004; 10: 475-80; PMID:15122249; http://dx.doi.org/10.1038/nm1039
   PubMed Web of Science ®Google Scholar
• Walker DG, Laherty R, Tomlinson FH, Chuah T, Schmidt C. Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy. J Clin Neurosci 2008; 15:114-21; PMID:18083572; http://dx.doi.org/10.1016/j.jocn.2007.08.007
   PubMed Web of Science ®Google Scholar
• Milano F, van Baal JW, Rygiel AM, Bergman JJ, Van Deventer SJ, Kapsenberg ML,. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes. J Immunol Methods 2007; 321:94-106; PMID:17336322; http://dx.doi.org/10.1016/j.jim.2007.01.004
   PubMed Web of Science ®Google Scholar
• Van Camp K, Cools N, Stein B, Van de Velde A, Goossens H, Berneman ZN,. Efficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes. J Immunol Methods. 2010; 354(1–2):1-10; PMID:20138047; http://dx.doi.org/10.1016/j.jim.2010.01.009
   PubMed Web of Science ®Google Scholar
• Jongmans W, Tiemessen DM, van Vlodrop IJ, Mulders PF, Oosterwijk E. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails. J Immunother 2005; 28:480-7; PMID:16113604; http://dx.doi.org/10.1097/01.cji.0000171290.78495.66
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Kühn U, Müller G, Steinbrink K, Paragnik L, Schmitt E,. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997; 27:3135-42; PMID:9464798; http://dx.doi.org/10.1002/eji.1830271209
   PubMed Web of Science ®Google Scholar
• Raïch-Regué D, Naranjo-Gómez M, Grau-López L, Ramo C, Pujol-Borrell R, Martínez-Cáceres E,. Differential effects of monophosphoryl lipid A and cytokine cocktail as maturation stimuli of immunogenic and tolerogenic dendritic cells for immunotherapy. Vaccine 2012; 30: 378-87; http://dx.doi.org/10.1016/j.vaccine.2011.10.081
   PubMed Web of Science ®Google Scholar
• Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005;6(8):769-76; PMID:15995707; http://dx.doi.org/10.1038/ni1223
   PubMed Web of Science ®Google Scholar
• Blander JM, Medzhitov R. On regulation of phagosome maturation and antigen presentation. Nat Immunol 2006;7(10):1029-35; PMID:16985500; http://dx.doi.org/10.1038/ni1006-1029
   PubMed Web of Science ®Google Scholar
• Schadendorf D, Ugurel S, Schuler-Thurner B, Nestle FO, Enk A, Bröcker EB,. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol 2006;17(4):563-70; PMID:16418308; http://dx.doi.org/10.1093/annonc/mdj138
   PubMed Web of Science ®Google Scholar
• Draube A, Klein-González N, Mattheus S, Brillant C, Hellmich M, Engert A,. Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis. PLoS One 2011;6(4):e18801; PMID:21533099; http://dx.doi.org/10.1371/journal.pone.0018801
   PubMed Web of Science ®Google Scholar
• Engell-Noerregaard L, Hansen TH, Andersen MH, Thor Straten P, Svane IM. Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters. Cancer Immunol Immunother 2009;58(1):1-14; PMID:18719915; http://dx.doi.org/10.1007/s00262-008-0568-4
   PubMed Web of Science ®Google Scholar
• Peng JC, Thomas R, Nielsen LK. Generation and maturation of dendritic cells for clinical application under serum-free conditions. J Immunother 2005;28(6):599-609; PMID:16224278; http://dx.doi.org/10.1097/01.cji.0000175491.21099.04
   PubMed Web of Science ®Google Scholar
• Dauer M, Lam V, Arnold H, Junkmann J, Kiefl R, Bauer C,. Combined use of toll-like receptor agonists and prostaglandin E(2) in the FastDC model: rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production. J Immunol Methods 2008;337(2):97-105; PMID:18657542; http://dx.doi.org/10.1016/j.jim.2008.07.003
   PubMed Web of Science ®Google Scholar
• Ten Brinke A, Karsten ML, Dieker MC, Zwaginga JJ, van Ham SM. The clinicalgrade maturation cocktail monophosphoryl lipid A plus IFN gamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization. Vaccine 2007; 25:7145-52; PMID:17719152; http://dx.doi.org/10.1016/j.vaccine.2007.07.031
   PubMed Web of Science ®Google Scholar
• Mailliard RB, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens CM, Kapsenberg ML,. alpha-type-I polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res 2004; 64:5934-7; PMID:15342370; http://dx.doi.org/10.1158/0008-5472.CAN-04-1261
   PubMed Web of Science ®Google Scholar
• Hansen M, Hjortø GM, Donia M, Met Ö, Larsen NB, Andersen MH,. Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy. Vaccine 2013 Jan;31(4):639-46; http://dx.doi.org/10.1016/j.vaccine.2012.11.053
   PubMed Web of Science ®Google Scholar
• Mitchell D, Olive C. Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases. Mol Immunol 2010; 47(11–12):2065-73; PMID:20451253
   PubMed Web of Science ®Google Scholar
• Dragicevic A, Dzopalic T, Vasilijic S, Vucevic D, Tomic S, Bozic B,. Signaling through Toll-like receptor 3 and Dectin-1 potentiates the capability of human monocyte-derived dendritic cells to promote T-helper 1 and T-helper 17 immune responses. Cytotherapy 2012; 14:598-607; PMID:22424215; http://dx.doi.org/10.3109/14653249.2012.667873
   PubMed Web of Science ®Google Scholar
• Chen W, Chan AS, Dawson AJ, Liang X, Blazar BR, Miller JS. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function. Biol Blood Marrow Transplant 2005; 11:23-34; PMID:15625541; http://dx.doi.org/10.1016/j.bbmt.2004.08.004
   PubMed Web of Science ®Google Scholar
• Whitmore MM, DeVeer MJ, Edling A, Oates RK, Simons B, Lindner D,. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res 2004; 64:5850-60; PMID:15313929; http://dx.doi.org/10.1158/0008-5472.CAN-04-0063
   PubMed Web of Science ®Google Scholar
• Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-5; PMID:11130078; http://dx.doi.org/10.1038/35047123
   PubMed Web of Science ®Google Scholar
• Johannsen A, Genolet R, Legler DF, Luther SA, Luescher IF. Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene mice. J Immunol 2010; 185:3445-55; PMID:20733200; http://dx.doi.org/10.4049/jimmunol.1001397
   PubMed Web of Science ®Google Scholar
• Tsujimoto H, Efron PA, Matsumoto T, Ungaro RF, Abouhamze A, Ono S,. Maturation of murine bone marrow-derived dendritic cells with poly(I:C) produces altered TLR-9 expression and response to CpG DNA. Immunol Lett 2006;107(2):155-62; PMID:17011046; http://dx.doi.org/10.1016/j.imlet.2006.09.001
   PubMed Web of Science ®Google Scholar
• Tada H, Aiba S, Shibata K, Ohteki T, Takada H. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect Immun 2005;73(12):7967-76; PMID:16299289; http://dx.doi.org/10.1128/IAI.73.12.7967-7976.2005
   PubMed Web of Science ®Google Scholar
• Hwang I, Ki D. Receptor-mediated T cell absorption of antigen presenting cell-derived molecules. Front Biosci (Landmark Ed) 2011;16:411-21; PMID:21196178; http://dx.doi.org/10.2741/3695
   PubMed Web of Science ®Google Scholar
• Alvarez D, Vollmann EH, von Andrian UH. Mechanisms and consequences of dendritic cell migration. Immunity 2008;29(3):325-42; PMID:18799141; http://dx.doi.org/10.1016/j.immuni.2008.08.006
   PubMed Web of Science ®Google Scholar
• Johnson LA, Jackson DG. Control of dendritic cell trafficking in lymphatics by chemokines. Angiogenesis 2014;17(2):335-45; PMID:24232855; http://dx.doi.org/10.1007/s10456-013-9407-0
   PubMed Web of Science ®Google Scholar
• Dudek AM, Martin S, Garg AD, Agostinis P. Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity. Front Immunol 2013;4:438; PMID:24376443; http://dx.doi.org/10.3389/fimmu.2013.00438
   PubMed Web of Science ®Google Scholar
• Garg NK, Dwivedi P, Prabha P, Tyagi RK. RNA pulsed dendritic cells: an approach for cancer immunotherapy. Vaccine 2013 Feb 6;31(8):1141-56; http://dx.doi.org/10.1016/j.vaccine.2012.12.027
   PubMed Web of Science ®Google Scholar
• Bae WK, Umeyama A, Chung IJ, Lee JJ, Takei M. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate. Cell Immunol 2010; 266:104-10; PMID:20933226; http://dx.doi.org/10.1016/j.cellimm.2010.09.004
   PubMed Web of Science ®Google Scholar
• Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, Van Broeckhoven C,. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 2001; 98:49-56; PMID:11418462; http://dx.doi.org/10.1182/blood.V98.1.49
   PubMed Web of Science ®Google Scholar
• Kyte JA, Kvalheim G, Lislerud K, thor Straten P, Dueland S, Aamdal S,. T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells. Cancer Immunol Immunother 2007;56(5):659-75; PMID:16947019; http://dx.doi.org/10.1007/s00262-006-0222-y
   PubMed Web of Science ®Google Scholar
• Yu Z, Sun H, Zhang T, Yang T, Long H, Ma B. Specific antitumor effects of tumor vaccine produced by autologous dendritic cells transfected with allogeneic osteosarcoma total RNA through electroporation in rats. Cancer Biol Ther 2009;8(10):973-80; PMID:19287216; http://dx.doi.org/10.4161/cbt.8.10.8281
   PubMed Web of Science ®Google Scholar
• Strayer DR, Carter WA, Brodsky I, Cheney P, Peterson D, Salvato P,. A controlled clinical trial with a specifically configured RNA drug, poly(I):poly(C) 12 U, in chronic fatigue syndrome. Clin Infect Dis 1994; 18:S88-95; PMID:8148460; http://dx.doi.org/10.1093/clinids/18.Supplement_1.S88
   PubMed Web of Science ®Google Scholar
• Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, Kluger C,. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med. 2009 Jul 6;206(7):1589-602; http://dx.doi.org/10.1084/jem.20090247
   PubMed Web of Science ®Google Scholar
• Wilson KL, Xiang SD, Plebanski M. Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope. Front Microbiol. 2015 Feb 6;6:29
   PubMed Web of Science ®Google Scholar
• Gobert M, Treilleux I, Bendriss-Vermare N, Bachelot T, Goddard-Leon S, Arfi V,. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 2009;69(5):2000-9; PMID:19244125; http://dx.doi.org/10.1158/0008-5472.CAN-08-2360
   PubMed Web of Science ®Google Scholar
• Lee AW, Truong T, Bickham K, Fonteneau JF, Larsson M, Da Silva I., A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. Vaccine 2002; 20:A8-A22; PMID:12477423; http://dx.doi.org/10.1016/S0264-410X(02)00382-1
   PubMed Web of Science ®Google Scholar
• Trepiakas R, Pedersen AE, Met O, Hansen MH, Berntsen A, Svane IM. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients. Vaccine 2008;26(23):2824-32; PMID:18450338; http://dx.doi.org/10.1016/j.vaccine.2008.03.054
   PubMed Web of Science ®Google Scholar
• Karlsen M, Hovden AO, Vogelsang P, Tysnes BB, Appel S. Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2. Scand J Immunol 2011; 74:135-43; PMID:21449940; http://dx.doi.org/10.1111/j.1365-3083.2011.02562.x
   PubMed Web of Science ®Google Scholar
• Möller I, Michel K, Frech N, Burger M, Pfeifer D, Frommolt P,. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application. J Immunother 2008; 31:506-19; PMID:18463533; http://dx.doi.org/10.1097/CJI.0b013e318177d9e5
   PubMed Web of Science ®Google Scholar
• Boullart AC, Aarntzen EH, Verdijk P, Jacobs JF, Schuurhuis DH, Benitez-Ribas D,. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration. Cancer Immunol Immunother 2008; 57:1589-97; PMID:18322684; http://dx.doi.org/10.1007/s00262-008-0489-2
   PubMed Web of Science ®Google Scholar
• Luft T, Jefford M, Luetjens P, Toy T, Hochrein H, Masterman KA,. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 2002; 100:1362-72; PMID:12149219; http://dx.doi.org/10.1182/blood-2001-12-0360
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim HO, Lee K, Baek EJ, Kim HS. Two-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacity. Vaccine 2010;28(16):2877-86; PMID:20156531; http://dx.doi.org/10.1016/j.vaccine.2010.01.061
   PubMed Web of Science ®Google Scholar
• Whitmore MM, DeVeer MJ, Edling A, Oates RK, Simons B, Lindner D,. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res 2004; 64:5850-60; PMID:15313929; http://dx.doi.org/10.1158/0008-5472.CAN-04-0063
   PubMed Web of Science ®Google Scholar
• Hoene V, Peiser M, Wanner R. Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19. J Leukoc Biol 2006; 80:1328-36; PMID:17000899; http://dx.doi.org/10.1189/jlb.0106011
   PubMed Web of Science ®Google Scholar
• Jung ID, Lee JS, Kim YJ, Jeong YI, Lee CM, Lee MG,. Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen-activated protein kinase. Immunology 2007; 121:533-44; PMID:17428311; http://dx.doi.org/10.1111/j.1365-2567.2007.02601.x
   PubMed Web of Science ®Google Scholar
• Liu Y, Shi G. Role of G protein-coupled receptors in control of dendritic cell migration. Biomed Res Int 2014;2014:738253; PMID:24734242
   PubMed Web of Science ®Google Scholar
• Paustian C, Caspell R, Johnson T, Cohen PA, Shu S, Xu S, Czerniecki BJ, Koski GK. Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells. Hum Immunol 2011;72(1):24-31; PMID:20951755; http://dx.doi.org/10.1016/j.humimm.2010.10.004
   PubMed Web of Science ®Google Scholar
• Tawab A, Fan Y, Read EJ, Kurlander RJ. Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes. Transfusion 2009; 49:536-47; PMID:19243546; http://dx.doi.org/10.1111/j.1537-2995.2008.02020.x
   PubMed Web of Science ®Google Scholar
• Johnson LA, Jackson DG. Control of dendritic cell trafficking in lymphatics by chemokines. Angiogenesis 2014;17(2):335-45; PMID:24232855; http://dx.doi.org/10.1007/s10456-013-9407-0
   PubMed Web of Science ®Google Scholar
• Villablanca EJ, Zhou D, Valentinis B, Negro A, Raccosta L, Mauri L,. Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo. J Leukoc Biol 2008; 84:871-9; PMID:18515328; http://dx.doi.org/10.1189/jlb.0108047
   PubMed Web of Science ®Google Scholar
• Kabashima K, Shiraishi N, Sugita K, Mori T, Onoue A, Kobayashi M,. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am J Pathol 2007; 171:1249-57; PMID:17823289; http://dx.doi.org/10.2353/ajpath.2007.070225
   PubMed Web of Science ®Google Scholar
• Beem E, Segal MS. Evaluation of stability and sensitivity of cell fluorescent labels when used for cell migration. J Fluoresc 2013; 23:975-87; PMID:23722994; http://dx.doi.org/10.1007/s10895-013-1224-8
   PubMed Web of Science ®Google Scholar
• Carrithers MD, Visintin I, Kang SJ, Janeway CA Jr. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 2000; 123:1092-101; PMID:10825349; http://dx.doi.org/10.1093/brain/123.6.1092
   PubMed Web of Science ®Google Scholar
• Peng Y, Zhang Y, Huang B, Luo Y, Zhang M, Li K,. Survival and migration of pre-induced adult human peripheral blood mononuclear cells in retinal degeneration slow (rds) mice three months after subretinal transplantation. Curr Stem Cell Res Ther 2014; 9:124-33; PMID:24350910; http://dx.doi.org/10.2174/1574888X09666131219115125
   PubMed Web of Science ®Google Scholar